Table of Contents
    Add a header to begin generating the table of contents

    Description

    An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are around 80 different autoimmune disorders ranging in severity from mild to disabling, depending on which system of the body is under attack and to what degree. The global autoimmune disease diagnostics market is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period, according to data and analytics company StrategyHelix. Growing patient awareness levels concerning autoimmune diseases, presence of favorable government initiatives, improved laboratory automation, rise in the geriatric population and growing prevalence of obesity, type 1 diabetes and other chronic diseases are expected to boost the market growth in the coming years.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for autoimmune disease diagnostics. The global autoimmune disease diagnostics market is segmented on the basis of type, gender, technology, and region. By type, it is categorized into systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. The localized autoimmune disease diagnostics segment held the largest market share in 2020. By gender, the autoimmune disease diagnostics market is divided into female, and male. The female segment accounted for the largest market share in 2020. Based on technology, the autoimmune disease diagnostics market is divided into enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, and others.

    The systemic autoimmune disease diagnostics market is further segmented into rheumatoid arthritis, psoriasis/psoriatic arthritis, systemic lupus erythematosus, multiple sclerosis, and others. Among them, rheumatoid arthritis segment held the largest market share in 2020. The localized autoimmune disease diagnostics market is further segmented into inflammatory bowel disease, type 1 diabetes, thyroid, and others. Among these, thyroid segment held the largest market share in 2020.

    The report has profiled some of the key players of the market such as Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux Inc., Bio-Rad AbD Serotec Limited, Bristol Myers Squibb (BMS), EUROIMMUN AG (PerkinElmer Inc.), F. Hoffmann-La Roche AG, Immuno Concepts Inc., INOVA Diagnostics Inc., Siemens Healthineers AG, SQI Diagnostics Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc (IMMCO Diagnostics Inc).

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the autoimmune disease diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


    Report Scope

    Type: systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics
    Gender: female, and male
    Technology: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, and others
    Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
    Years Considered: this report covers the period 2017 to 2027


    Key Benefits for Stakeholders

    Get a comprehensive picture of the global autoimmune disease diagnostics market
    Identify regional strategies and strategic priorities on the basis of local data and analysis
    Pinpoint growth sectors and trends for investment
    Understand what the future of the global autoimmune disease diagnostics market looks like
    Identify the competitive landscape and window of opportunity


    Table of Contents

    1. Market Definition
    2. Research Methodology
    3. Market Data & Outlook
    3.1 Market Value
    3.2 Market Value Forecast
    4. Autoimmune Disease Diagnostics Market by Type
    4.1 Systemic Autoimmune Disease Diagnostics
    4.2 Localized Autoimmune Disease Diagnostics
    5. Autoimmune Disease Diagnostics Market by Gender
    5.1 Female
    5.2 Male
    6. Autoimmune Disease Diagnostics Market by Technology
    6.1 Enzyme-Linked Immunosorbent Assay (Elisa)
    6.2 Indirect Immunofluorescence (Iif)
    6.3 Immunoblot
    6.4 Multiplex Immunoassays
    6.5 Others
    7. Autoimmune Disease Diagnostics Market by Region
    7.1 North America
    7.2 Asia Pacific
    7.3 Europe
    7.4 Rest Of The World (Row)
    8. Company Profiles
    8.1 Abbott Laboratories
    8.2 Beckman Coulter Inc. (Danaher Corporation)
    8.3 Becton, Dickinson and Company
    8.4 bioMerieux, Inc.
    8.5 Bio-Rad AbD Serotec Limited
    8.6 Bristol Myers Squibb (BMS)
    8.7 EUROIMMUN AG (PerkinElmer, Inc.)
    8.8 F. Hoffmann-La Roche AG
    8.9 Immuno Concepts, Inc.
    8.10 INOVA Diagnostics, Inc.
    8.11 Siemens Healthineers AG
    8.12 SQI Diagnostics, Inc.
    8.13 Thermo Fisher Scientific Inc.
    8.14 Trinity Biotech plc (IMMCO Diagnostics Inc)
    9. Appendix
    9.1 About StrategyHelix
    9.2 Disclaimer


    StrategyHelix Black LOGO

    REQUEST SAMPLE

    Please fill out our form and we will get back to you.

    Global Autoimmune Disease Diagnostics Market 2021

    StrategyHelix Black LOGO

    CUSTOM RESEARCH

    Custom projects can be researched to match your unique needs.

    Global Autoimmune Disease Diagnostics Market 2021

    login